New User? Sign Up | Sign In

Insider Trading - Revance Therapeutics Inc. (RVNC)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
RVNC Insider Trading Transactions for Revance Therapeutics Inc.
Goto page 0, 1, 2, 3, 4, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-09-28
Sale
2020-09-30
9:21 pm
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
33,119 $26.18 $867,055 576,922
(Indirect
Direct)
View
2020-10-29
Sale
2020-10-30
8:24 pm
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
33,119 $26.15 $865,949 543,803
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-07-16
Option Award
2019-07-18
8:29 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Nolet Chris
Director
9,000 $0 18,000
(Direct)
View
2019-07-16
Option Award
2019-07-18
8:29 pm
N/A
2029-07-15
Revance Therapeutics Inc. RVNC Nolet Chris
Director
18,000 $12.32 18,000
(Direct)
View
2019-10-13
Option Award
2019-10-15
8:23 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
200,000 $0 740,000
(Direct)
View
2019-10-13
Option Award
2019-10-15
8:23 pm
N/A
2029-10-12
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
740,000 $12.18 740,000
(Direct)
View
2019-12-14
Tax Withholding
2019-12-17
7:56 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
2,971 $15.99 85,952
(Direct)
View
2019-12-15
Tax Withholding
2019-12-17
7:57 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
1,556 $15.99 22,367
(Direct)
View
2019-12-15
Tax Withholding
2019-12-17
8:00 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
576 $15.99 11,492
(Direct)
View
2019-12-31
Other
2020-01-03
6:42 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
504 $10.82 22,871
(Direct)
View
2019-12-31
Other
2020-01-03
6:46 pm
N/A
N/A
Revance Therapeutics Inc. RVNC McDowell Caryn Gordon
VP
382 $10.82 24,317
(Direct)
View
2019-12-31
Other
2020-01-03
6:48 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
382 $10.82 13,784
(Direct)
View
2020-01-15
Tax Withholding
2020-01-17
8:12 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
4,441 $22.89 81,511
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:16 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
25,000 $0 146,500
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:16 pm
N/A
2030-01-22
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
146,500 $22.32 146,500
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:18 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
20,000 $0 100,000
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:18 pm
N/A
2030-01-22
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
100,000 $22.32 100,000
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:21 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
16,500 $0 97,500
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:21 pm
N/A
2030-01-22
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
97,500 $22.32 97,500
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:22 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
200,000 $0 413,500
(Direct)
View
2020-02-18
Option Award
2020-02-19
8:18 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Moxie Dwight
VP
25,000 $0 170,000
(Direct)
View
2020-02-18
Option Award
2020-02-19
8:18 pm
N/A
2030-02-17
Revance Therapeutics Inc. RVNC Moxie Dwight
VP
170,000 $25.93 170,000
(Direct)
View
2020-02-15
Tax Withholding
2020-02-19
8:20 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
288 $25.33 33,496
(Direct)
View
2020-02-15
Tax Withholding
2020-02-19
8:21 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
576 $25.33 38,795
(Direct)
View
2020-02-15
Tax Withholding
2020-02-19
8:22 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
3,325 $25.33 103,186
(Direct)
View
2020-02-15
Tax Withholding
2020-02-19
8:23 pm
N/A
N/A
Revance Therapeutics Inc. RVNC McDowell Caryn Gordon
VP
864 $25.33 23,453
(Direct)
View
2020-03-15
Tax Withholding
2020-03-17
8:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
1,354 $15.5 101,832
(Direct)
View
2020-04-15
Tax Withholding
2020-04-17
7:51 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
432 $14.8 33,064
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:33 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
6,000 $0 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:33 pm
N/A
2030-05-13
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
12,000 $19.4 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
6,000 $0 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:34 pm
N/A
2030-05-13
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
12,000 $19.4 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:35 pm
N/A
N/A
Revance Therapeutics Inc. RVNC BYRNES ROBERT F
Director
6,000 $0 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:35 pm
N/A
2030-05-13
Revance Therapeutics Inc. RVNC BYRNES ROBERT F
Director
12,000 $19.4 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:39 pm
N/A
N/A
Revance Therapeutics Inc. RVNC GARDNER PHYLLIS
Director
6,000 $0 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:39 pm
N/A
2030-05-13
Revance Therapeutics Inc. RVNC GARDNER PHYLLIS
Director
12,000 $19.4 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:41 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Nolet Chris
Director
6,000 $0 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:41 pm
N/A
2030-05-13
Revance Therapeutics Inc. RVNC Nolet Chris
Director
12,000 $19.4 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:42 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
6,000 $0 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:42 pm
N/A
2030-05-13
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
12,000 $19.4 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:45 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Beraud Jill
Director
6,000 $0 12,000
(Direct)
View
2020-05-14
Option Award
2020-05-15
6:45 pm
N/A
2030-05-13
Revance Therapeutics Inc. RVNC Beraud Jill
Director
12,000 $19.4 12,000
(Direct)
View
2020-06-30
Other
2020-07-02
8:18 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
763 $13.8 39,558
(Direct)
View
2020-06-30
Other
2020-07-02
8:20 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
1,000 $13.8 34,064
(Direct)
View
2020-07-23
Option Award
2020-07-27
7:57 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
610,041 $0 8,867
(Direct)
View
2020-07-23
Option Award
2020-07-27
7:57 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
57,251 $0 8,867
(Direct)
View
2020-07-23
Option Award
2020-07-27
7:57 pm
N/A
2029-05-13
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
44,828 $2.54 8,867
(Direct)
View
2020-07-23
Option Award
2020-07-27
7:57 pm
N/A
2029-12-19
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
8,867 $2.54 8,867
(Direct)
View
2020-07-23
Option Award
2020-09-30
9:19 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
57,251 $0 610,041
(Direct)
View
2020-07-23
Option Award
2020-09-30
9:19 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Rankin Aubrey
President
610,041 $0 610,041
(Indirect)
View
2020-09-30
Option Award
2020-10-02
8:30 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Moxie Dwight
VP
12,250 $0 33,014
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
8:30 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Moxie Dwight
VP
4,236 $25.14 33,014
(Direct)
View
2020-09-30
Option Award
2020-10-02
8:31 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
17,500 $0 111,950
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
8:31 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
7,382 $25.14 111,950
(Direct)
View
2020-09-30
Option Award
2020-10-02
8:32 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
15,750 $0 49,862
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
8:32 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
5,446 $25.14 49,862
(Direct)
View
2020-09-30
Option Award
2020-10-02
8:33 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
301,000 $0 571,231
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
8:33 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
143,269 $25.14 571,231
(Direct)
View
2020-09-30
Option Award
2020-10-02
8:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
17,500 $0 45,513
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
8:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
Chief Commercial Officer
6,051 $25.14 45,513
(Direct)
View
2020-07-23
Option Award
2020-10-15
6:57 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
264,439 $0 769,564
(Direct)
View
2020-07-23
Option Award
2020-10-15
6:57 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
50,913 $0 769,564
(Indirect)
View
2020-07-23
Tax Withholding
2020-10-15
6:57 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
66,106 $27.62 769,564
(Direct)
View
Goto page 0, 1, 2, 3, 4, Next